MedPath

The hysteroscopic morcellator versus the bipolar resectoscope for removal of residual placental tissue: a randomized controlled trial.

Completed
Conditions
remainders of the afterbirth in the womb
residual placental tissue
10035129
10046828
Registration Number
NL-OMON38083
Lead Sponsor
Catharina-ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
37
Inclusion Criteria

Patients with residual placental tissue as seen by ambulant diagnostic hysteroscopy who are planned for hysteroscopic surgery.

Exclusion Criteria

Patients with:
• Visual or pathological (e.g. on biopsy) evidence of malignancy
preoperatively or at the time of operation.
• Untreated cervical stenosis making safe access for operative hysteroscopy
impossible as diagnosed preoperatively or at the time of operation.
• A contra-indication for operative hysteroscopy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Installation and operating time.<br /><br>Performing a second look hysteroscopy after 6 weeks checking for intrauterine<br /><br>adhesions, comparing the 2 techniques.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Comparing data on peri- and post operative complications (e.g. fluid deficit,<br /><br>conversion rates, perforation, burns, postoperative infection), availability of<br /><br>tissue for pathology analysis and pathology results, and efficiency at 6 weeks<br /><br>follow-up. </p><br>
© Copyright 2025. All Rights Reserved by MedPath